Lupin gets USFDA nod to market antipsychotic drug Garima16 Oct 2018 9:16 AM ISTNew Delhi: Drug firm Lupin Monday said it has received tentative nod from the US health regulator to market its antipsychotic Lurasidone Hydrochloride...
Novo Nordisk picks AstraZeneca executive to head biopharma business Medical Dialogues Bureau16 Oct 2018 9:00 AM ISTCOPENHAGEN: Novo Nordisk has hired AstraZeneca's head of cardiovascular and metabolic diseases to head its biopharma business, which has been...
Looking to establish presence in China: Lupin Medical Dialogues Bureau15 Oct 2018 2:07 PM ISTMumbai: Drug major Lupin is looking to establish presence in China as part of its strategy to strengthen its markets in the Asia Pacific region, a...
Dr Reddy's Laboratories recalls 35,000 tubes of skin infection cream from US Medical Dialogues Bureau15 Oct 2018 2:05 PM ISTNew Delhi: Dr Reddy's Laboratories' US arm is recalling over 35,000 tubes of Nystatin and Triamcinolone Acetonide cream on account of failed...
Sun Pharma to Pump in Rs 200 Crore More in Assam Plant Medical Dialogues Bureau15 Oct 2018 2:01 PM ISTGuwahati: Assam government on Saturday said medicine firm Sun Pharma will invest an additional Rs 200 crore at its plant in the state to augment...
Embattled Chinese drug maker to get 43 million dollars in government support Medical Dialogues Bureau15 Oct 2018 9:04 AM ISTSHANGHAI: - A Chinese city government has given 300 million yuan ($43 million) to drug maker Zhejiang Huahai Pharmaceuticals, the company said, after...
Eli Lilly Launches Olumiant-once-daily oral therapy for rheumatoid arthritis In India Medical Dialogues Bureau14 Oct 2018 11:33 AM ISTRheumatoid Arthritis is a systemic autoimmune disease characterized by inflammation and progressive destruction of jointsNew Delhi: Drug firm Eli...
Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation for Oncolytic Virotherapies Medical Dialogues Bureau14 Oct 2018 10:16 AM ISTNew Delhi: Themis announced that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max...
Pfizer announces $3 million grant for ASPIRE Breast Cancer Research Medical Dialogues Bureau14 Oct 2018 9:58 AM ISTNew Delhi: Pfizer Inc. has recently announced the recipients of the Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Breast...
Bristol-Myers to invest in Compugen, collaborate in clinical trials Medical Dialogues Bureau14 Oct 2018 9:16 AM ISTTEL AVIV - Bristol-Myers Squibb Co and Israel’s Compugen said on Thursday they will collaborate in clinical trials for patients with advanced solid...
Lundbeck gets DCGI nod for Brintellix antidepressant, launches in India Medical Dialogues Bureau13 Oct 2018 12:46 PM ISTBrintellix, is a novel multimodal antidepressant, which has been specifically designed to inhibit serotonin reuptake and modulate serotonergic...
Zydus Cadila gets tentative USFDA nod for Linagliptin and Metformin Hydrochloride tablets Medical Dialogues Bureau13 Oct 2018 12:26 PM ISTNew Delhi: Drug firm Zydus Cadila Friday said it has received tentative approval from the US health regulator to market Linagliptin and Metformin...
